高风险静脉曲张无创评估是否需要瞬时弹性成像?REAL 研究经验
该研究基于 RESIST-HCV 队列中 1381 例丙型肝炎肝硬化患者,评估仅用实验室指标(血小板计数与白蛋白)的简易算法预测中/大食管静脉曲张的性能,并与 Baveno VI 及扩展 Baveno VI 标准比较。结果显示 RESIST-HCV 标准可使超过 30% 患者避免内镜筛查,其性能与瞬时弹性成像标准相同。
要点
- RESIST-HCV 标准(血小板 >120×10^3/μL 且白蛋白 >3.6 g/dL)在训练队列避免内镜比例 36.5%,阴性预测值 99.2%。
- 验证队列中 30% 患者符合 RESIST-HCV 标准,阴性预测值 98.1%。
- 在 RESIST-HCV 标准基础上加做瞬时弹性成像使约 25% 患者避免内镜,阴性预测值 98.2%。
核心结论
- 易用的 RESIST-HCV 算法可使超过 30% 的患者避免为筛查高风险食管静脉曲张而接受内镜,且具有与瞬时弹性成像标准相同的性能标准。
- 使用这些标准可简化门静脉高压的诊断。
研究设计与样本
- 研究纳入 1381 例丙型肝炎肝硬化患者,均在开始直接抗病毒药物治疗 1 年内接受内镜和瞬时弹性成像检查。
- 采用多因素逻辑回归分析筛选与中/大食管静脉曲张独立相关的实验室变量以建立 RESIST-HCV 标准。
- RESIST-HCV 标准在单中心(巴勒莫)训练队列中测试,并在 RESIST-HCV 项目其他 21 个中心的验证队列中验证。
主要发现
- 整个队列中,Baveno VI 标准组 216 例中 5 例(2.3%)存在中/大食管静脉曲张,扩展 Baveno VI 标准组 497 例中 13 例(2.6%)存在中/大食管静脉曲张。
- 血小板计数和血清白蛋白水平与中/大食管静脉曲张独立相关。
- 最佳截断值为血小板计数大于 120×10^3/μL(阴性预测值 97.2%)和血清白蛋白水平大于 3.6 g/dL(阴性预测值 94.7%)。
- 训练队列 326 例中 119 例(36.5%)符合 RESIST-HCV 标准,阴性预测值为 99.2%。
- 验证队列 1055 例中 315 例(30%)符合 RESIST-HCV 标准,阴性预测值为 98.1%。
关键数值与推荐
- Baveno VI 标准:整个队列 216 例中 5 例(2.3%)存在中/大食管静脉曲张。
- 扩展 Baveno VI 标准:整个队列 497 例中 13 例(2.6%)存在中/大食管静脉曲张。
- RESIST-HCV 标准截断值:血小板计数大于 120×10^3/μL(阴性预测值 97.2%),血清白蛋白大于 3.6 g/dL(阴性预测值 94.7%)。
- RESIST-HCV 标准在训练队列中阴性预测值 99.2%(119/326 符合标准),在验证队列中阴性预测值 98.1%(315/1055 符合标准)。
- RESIST-HCV 标准加瞬时弹性成像后阴性预测值 98.2%,约 25% 患者避免内镜。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The Baveno VI consensus guidelines and an expanded algorithm suggest that transient elastography (TE) and platelet (PLT) count can be used to identify patients with cirrhosis who can avoid esophagogastroduodenoscopy (EGD). The primary aims of this study were to assess the ability of a simple algorithm, which uses only laboratory parameters, to predict medium/large esophageal varices (EV) in patients with hepatitis C virus (HCV) and cirrhosis from the Rete Sicilia Selezione Terapia-HCV (RESIST-HCV) cohort and to compare the performance of the algorithm with Baveno VI and Expanded Baveno VI criteria. The secondary aim was to assess the role of TE in ruling out large EV. METHODS: In total, 1,381 patients with HCV-associated cirrhosis who had EGD and TE within 1 year of starting treatment with direct-acting antivirals were evaluated. Using multivariate logistic analysis, laboratory variables were selected to determine which were independently associated with medium/large EV to create the RESIST-HCV criteria. These criteria were tested in a training cohort with patients from a single center (Palermo) and validated with patients from the 21 other centers of the RESIST-HCV program (validation cohort). RESULTS: In the entire cohort, medium/large EV were identified in 5 of 216 patients (2.3%) using the Baveno VI criteria and 13 of 497 patients (2.6%) using the Expanded Baveno VI criteria. PLT count and albumin level were independently associated with medium/large EV. The best cut-off values were a PLT count greater than 120 × 10 cells/μL and serum albumin level greater than 3.6 g/dL; negative predictive values (NPVs) were 97.2% and 94.7%, respectively. In the training cohort of 326 patients, 119 (36.5%) met the RESIST-HCV criteria and the NPV was 99.2%. Among 1,055 patients in the validation cohort, 315 (30%) met the RESIST-HCV criteria and the NPV was 98.1%. Adding TE to the RESIST-HCV criteria reduced the avoided EGDs for approximately 25% of patients and the NPV was 98.2%. DISCUSSION: The "easy-to-use" RESIST-HCV algorithm avoids EGD for high-risk EV screening for more than 30% of patients and has the same performance criteria as TE. Using these criteria simplifies the diagnosis of portal hypertension.
引用
- Calvaruso V, Cacciola I, Licata A, et al. Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience. Am J Gastroenterol. 2019. PMID: 31135449. doi:10.14309/ajg.0000000000000266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。